PDLI Depreciation & Amortization
Pdl Biopharma Inc · Depreciation & Amortization
PDLI Depreciation & Amortization
Latest reported$1.50Mperiod ending
PDLI TTM Depreciation & Amortization ($3.20M → $1.50M)
TTM Depreciation & Amortization
High-resolution chart · PNG
PDLI depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 1,501,000 | |
| 3,806,000 | |
| 6,616,000 | |
| 7,192,000 | |
| 9,279,000 | |
| 8,414,000 | |
| 11,110,000 | |
| 15,831,000 | |
| 20,505,000 | |
| 25,202,000 | |
| 24,967,000 | |
| 24,689,000 | |
| 24,452,000 | |
| 24,195,000 | |
| 18,050,000 | |
| 12,044,000 | |
| 6,041,000 | |
| -7,177,000 | |
| 39,000 | |
| 40,000 | |
| 19,000 | |
| 7,270,000 | |
| -11,742,000 | |
| 179,000 | |
| 6,186,000 | |
| 5,990,000 | |
| 17,518,000 | |
| 5,637,000 | |
| -218,000 | |
| 146,000 | |
| 698,000 | |
| 946,000 | |
| 1,177,000 | |
| 1,322,000 | |
| 1,390,000 | |
| 1,405,000 | |
| 1,177,000 | |
| 928,000 | |
| 609,000 | |
| 330,000 | |
| 219,000 | |
| 139,000 | |
| 138,000 | |
| 991,000 | |
| 3,688,000 | |
| 8,658,000 | |
| 14,382,000 | |
| 22,494,000 | |
| 35,779,000 | |
| 48,169,000 | |
| 59,089,000 | |
| 66,835,000 | |
| 70,356,000 | |
| 72,032,000 | |
| 75,516,000 | |
| 78,015,000 | |
| 74,035,000 | |
| 71,953,000 | |
| 68,744,000 | |
| 54,897,000 | |
| 43,051,000 | |
| 30,111,000 | |
| 16,962,000 | |
| 15,068,000 | |
| 14,954,000 | |
| 13,970,000 | |
| 12,395,000 | |
| 10,495,000 | |
| 8,549,000 | |
| 7,097,000 | |
| 6,353,000 | |
| 6,162,000 | |
| 5,965,000 | |
| 5,764,000 | |
| 5,711,000 | |
| 5,503,000 | |
| 5,351,000 | |
| 4,902,000 | |
| 4,551,000 | |
| 4,198,000 | |
| 3,696,000 | |
| 3,634,000 | |
| 3,451,000 | |
| 3,500,000 | |
| 3,800,000 | |
| 3,800,000 | |
| 3,800,000 | |
| 3,700,000 | |
| 3,400,000 | |
| 3,300,000 | |
| 3,200,000 | |
| 3,200,000 | |
| 3,200,000 | |
| 3,200,000 |